SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Ozaras, G. Corti, S. Ruta, K. Lacombe, M.U. Mondelli, W.L. Irwing, M. Puoti, A. Khalighi, M.L. Santos, A. Harxhi, I. Lazarevic, V. Soriano, J. Gervain, H. Leblebicioglu, D. Salmon, J.E. Arends, Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe, Clinical Microbiology and Infection, 2015, 21, 11, 1027

    CrossRef

  2. 2
    Vasilios Papastergiou, Rosa Lombardi, Douglas MacDonald, Emmanuel A. Tsochatzis, Global Epidemiology of Hepatitis B Virus (HBV) Infection, Current Hepatology Reports, 2015, 14, 3, 171

    CrossRef

  3. 3
    C. Wendy Spearman, Mark W. Sonderup, Health disparities in liver disease in sub-Saharan Africa, Liver International, 2015, 35, 9
  4. 4
    Haruki Komatsu, Ayano Inui, Hepatitis B virus infection in children, Expert Review of Anti-infective Therapy, 2015, 1

    CrossRef

  5. 5
    Maud Lemoine, Serge Eholié, Karine Lacombe, Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach, Journal of Hepatology, 2015, 62, 2, 469

    CrossRef

  6. 6
    M. H. Cho, H. Jeong, Y. S. Kim, J.-W. Kim, G. Jung, 2-Amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor, Journal of Viral Hepatitis, 2014, 21, 12
  7. 7
    E. Teshale, M. Lu, L. B. Rupp, S. D. Holmberg, A. C. Moorman, P. Spradling, V. Vijayadeva, J. A. Boscarino, M. A. Schmidt, S. C. Gordon, APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS), Journal of Viral Hepatitis, 2014, 21, 12
  8. 8
    Philippa C. Matthews, Anna Maria Geretti, Philip J.R. Goulder, Paul Klenerman, Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa, Journal of Clinical Virology, 2014, 61, 1, 20

    CrossRef

  9. 9
    Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, Nisreen Z. Khalaf, Nisha A. Viswan, Mohammed N. Al Ahdal, Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients, Liver International, 2014, 34, 7
  10. 10
    S. Aoudjane, M. Chaponda, A. A. Gonzalez del Castillo, J. O'Connor, M. Noguera, A. Beloukas, M. Hopkins, S. Khoo, J. J. van Oosterhout, A. M. Geretti, Hepatitis B Virus Sub-genotype A1 Infection Is Characterized by High Replication Levels and Rapid Emergence of Drug Resistance in HIV-Positive Adults Receiving First-line Antiretroviral Therapy in Malawi, Clinical Infectious Diseases, 2014, 59, 11, 1618

    CrossRef

  11. 11
    Yusuke Shimakawa, Maud Lemoine, Maimuna Mendy, Harr Freeya Njai, Umberto D’Alessandro, Andrew Hall, Mark Thursz, Ramou Njie, Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa, Tropical Medicine and Health, 2014, 42, 2SUPPLEMENT, S59

    CrossRef

  12. 12
    Jiezuan Yang, Jiajia Chen, Jianqin He, Yirui Xie, Yixing Zhu, Hongcui Cao, Lanjuan Li, Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection, Cellular and Molecular Immunology, 2014, 11, 4, 343

    CrossRef

  13. 13
    J. Jia, A different look at the management of chronic hepatitis B in a resource-constrained country, Journal of Viral Hepatitis, 2013, 20,
  14. 14
    Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Mohammad Helal Uddin, Md. Sakirul Islam Khan, HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 4, 363

    CrossRef

  15. 15
    Bénédicte De Vroey, Christophe Moreno, Wim Laleman, Marc van Gossum, Isabelle Colle, Chantal de Galocsy, Philippe Langlet, Geert Robaeys, Hans Orlent, Peter Michielsen, Jean Delwaide, Hendrik Reynaert, François D’Heygere, Dirk Sprengers, Stefan Bourgeois, Collins Assene, Bertrand Vos, Réginald Brenard, Michael Adler, Jean Henrion, Pierre Deltenre, Hepatitis B virus and hepatitis C virus infections in Belgium, European Journal of Gastroenterology & Hepatology, 2013, 25, 5, 613

    CrossRef

  16. 16
    Emmanuel Ochola, Ponsiano Ocama, Christopher G Orach, Ziadah K Nankinga, Joan N Kalyango, Willi McFarland, Charles Karamagi, High burden of hepatitis B infection in Northern Uganda: results of a population-based survey, BMC Public Health, 2013, 13, 1, 727

    CrossRef

  17. 17
    Sara A Healy, Sonia Gupta, Ann J Melvin, HIV/HBV coinfection in children and antiviral therapy, Expert Review of Anti-infective Therapy, 2013, 11, 3, 251

    CrossRef

  18. 18
    Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Md. Sakirul Islam Khan, Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides, Expert Opinion on Biological Therapy, 2013, 13, 7, 1063

    CrossRef

  19. 19
    F. J. Muro, S. P. Fiorillo, P. Sakasaka, C. Odhiambo, E. A. Reddy, C. K. Cunningham, A. M. Buchanan, Seroprevalence of Hepatitis B and C Viruses Among Children in Kilimanjaro Region, Tanzania, Journal of the Pediatric Infectious Diseases Society, 2013, 2, 4, 320

    CrossRef

  20. 20
    Howard Thomas, Treatment of chronic Hepatitis B in resource-constrained countries: an economic solution is required, Journal of Viral Hepatitis, 2013, 20,
  21. You have free access to this content21
    Hong Ma, Jidong Jia, Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue, Liver International, 2013, 33,
  22. 22
    Philip J Peters, Barbara J Marston, Paul J Weidle, John T Brooks, Hunter's Tropical Medicine and Emerging Infectious Disease, 2013,

    CrossRef

  23. 23
    Yu-Bao Zheng, Shi-Bin Xie, Dong-Ying Xie, Liang Peng, Zi-Ying Lei, Hong Deng, Bin-Liang Lin, Chao-Shuang Lin, Zhi-Xin Zhao, Wei-Min Ke, Zhi-Liang Gao, A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study, Hepatology International, 2012, 6, 4, 727

    CrossRef

  24. 24
    Corinna Klingler, Andrea I. Thoumi, Vinod S. Mrithinjayam, Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique, Vaccine, 2012, 31, 1, 252

    CrossRef

  25. 25
    Steven J. Scaglione, Anna S.F. Lok, Effectiveness of Hepatitis B Treatment in Clinical Practice, Gastroenterology, 2012, 142, 6, 1360

    CrossRef

  26. 26
    Erratum, Liver International, 2012, 32, 1
  27. 27
    Maud Lemoine, Pierre-Marie Girard, Mark Thursz, Gilles Raguin, In the shadow of HIV/AIDS: Forgotten diseases in sub-Saharan Africa: Global health issues and funding agency responsibilities, Journal of Public Health Policy, 2012, 33, 4, 430

    CrossRef

  28. 28
    Jiezuan Yang, Ping Yi, Li Wei, Zherong Xu, Yunbo Chen, Lingling Tang, Lanjuan Li, Phenotypes and clinical significance of circulating CD4+CD25+ regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF), Journal of Translational Medicine, 2012, 10, 1, 193

    CrossRef